Dexcom (DXCM) FY2021 results: revenue $2.4 billion, up 27.1% on the year
Dexcom Inc. (DXCM) reported revenue of $2.4 billion for fiscal 2021, the year ended 31 December 2021, up 27.1% on the year before. Net income was $217 million, down 60.5%, and diluted earnings per share $0.53. The figures are the company's own, from the 10-K it filed with the SEC on 14 February 2022.
Revenue
$2.4 billion
+27.1% on the year
FY2014FY2021
Operating margin
10.9%
15.5% a year earlier
FY2014FY2021
Net income
$217 million
-60.5% on the year
FY2014FY2021
Diluted EPS
$0.53
-60.2% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
442
476
314
-7.0%
Capital expenditure
389
199
180
+95.6%
Free cash flow
53.3
277
134
-80.7%
Free cash flow margin
2.2%
14.4%
9.1%
Cash from investing
-216
-1,018
-1,015
Cash from financing
10.4
912
10.7
-98.9%
Depreciation and amortisation
102
67.1
48.7
+52.0%
Share-based compensation
113
119
103
-5.0%
Buybacks
0.0
0.0
0.0
Diluted shares, weighted
429m
420m
92m
+2.0%
Shares outstanding at period end
97m
96m
92m
+0.9%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
2,042
1,552
883
+31.6%
Non-controlling interest
n/a
275
n/a
Debt
1,982
1,667
1,060
+18.9%
Operating lease liabilities
98.6
102
72.4
-3.1%
Finance lease liabilities
57.0
54.0
14.4
+5.6%
Other liabilities
754
641
366
+17.6%
Total liabilities and equity
4,933
4,290
2,395
+15.0%
Fixed assets
802
515
321
+55.6%
Goodwill
26.5
19.3
18.6
+37.3%
Intangible assets
31.5
n/a
n/a
Investments
1,681
n/a
n/a
Securities held for sale or to maturity
n/a
1,890
1,087
Cash and equivalents
1,053
818
446
+28.7%
Receivables
514
428
286
+20.0%
Inventory
357
235
120
+52.2%
Other assets
469
385
116
+21.7%
Total assets
4,933
4,290
2,395
+15.0%
10-K for the year ended 31 December 2021, filed 14 February 2022: the filing.